Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care
- 29 April 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet Oncology
- Vol. 21 (6), 748-750
- https://doi.org/10.1016/s1470-2045(20)30242-4
Abstract
No abstract availableFunding Information
- Cancer Research UK (C8640/A23385)
This publication has 7 references indexed in Scilit:
- COVID-19: global consequences for oncologyThe Lancet Oncology, 2020
- Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?BMJ, 2020
- Wasting the doctor's time? A video-elicitation interview study with patients in primary careSocial Science & Medicine, 2017
- Improving early diagnosis of symptomatic cancerNature Reviews Clinical Oncology, 2016
- Attributions of Cancer ‘Alarm’ Symptoms in a Community SamplePLOS ONE, 2014
- Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?British Journal of Cancer, 2013
- The Model of Pathways to Treatment: Conceptualization and integration with existing theoryBritish Journal of Health Psychology, 2012